Life Science Intelligence (LSI) announced today that more than 25 medical device companies with emerging technologies will be showcased at their upcoming Emerging Medical Technologies Spotlight – an online meeting being held on August 11, 2010 at 11 a.m. Eastern, sponsored by Rutan, with additional sponsorships available.
The program will feature select privately-held companies that are: At various stages of development
- Aiming to disrupt several medical device markets
- Seeking partnerships or licensing deals with larger medical technology companies
- Seeking investors
- Seeking acquisition
Attendees to the meeting will get online access to:
- 10-15 minute CEO Presentations - audio and slides
- The Notebook of Executive Summaries
- Detailed Information, Including: Development Stage, Competitive Landscape and Positioning, Technological Advantage, Target Markets, Sales Forecasts, Strategic Partnering Opportunities, Financial & Fund Raising Status, Management Team, IP Position, Exit Strategy, Contact Details
- The “Live” Event on August 11, 2010 and the “Replay” for up to 12 Months Thereafter
- Optional Networking
LSI's online venue provides CEOs of emerging medical device technologies with a secure platform to efficiently share their business development and investment opportunities to a prominent investment and partnering audience. Interested entrepreneurs may apply to present for the August 11th meeting.
To register to attend online or for additional details, visit http://www.emtspotlight.com/.
About Life Science Intelligence (LSI)® LSI delivers high-quality market data and competitive intelligence to medical technology executives, entrepreneurs, and investors. LSI produces the comprehensive Emerging Medical Technologies® database, quarterly Emerging Medical Technologies® online meetings, traditional market reports, deeply segmented and frequently updated market agents, and global custom market research. http://www.lifescienceintelligence.com/
Contact: Life Science Intelligence Scott Pantel, 1-714-847-3540 scott@LifeScienceIntelligence.com
About OrthoAccel Technologies, Inc.
Based in Houston, Texas, OrthoAccel Technologies, Inc. is a privately owned medical device company currently engaged in the development, manufacturing, and marketing of products to enhance dental care and orthodontic treatment.
About the AcceleDent System
AcceleDent represents the first clinical approach to safely accelerate orthodontic tooth movement via modulating biology. The device has been studied clinically and applies gentle pulsing forces in combination with standard orthodontics to move teeth faster through accelerated bone remodeling. Importantly, the device works complementary with all existing orthodontic technologies. AcceleDent is neither FDA cleared nor FDA approved; it is currently investigational only in the United States. More information can be found at www.acceledent.com and www.acceledent.co.uk or requested via info@orthoaccel.com